Clinical Trials: Ensuring Quality and Standardization
- 35 Downloads
The number of clinical trials in the United States and worldwide is increasing rapidly. ClinicalTrials.gov, which started in the year 2000, registered a total of 2119 trials, whereas in 2019, that number is 309,531, which is nearly a 150-fold increase . Of the 309,531 trials registered in 2019, 244,831 (79%) are interventional, with 25,857 - or approximately 11% - involving a surgical procedure. With this rise in the number of clinical trials, there is an increased need to ensure that human subjects research being conducted is done in a manner that is ethical and the data collected, analyzed, and reported are of high quality and transparent. To meet this need, organizations ranging from academic centers to large consortia that conduct clinical trials to the National Institutes of Health now have implemented training programs and defined standards for all professionals participating in the conduct of clinical trials. We will review some of these standards, as well as other components of clinical trials to ensure quality and standardization.
- 1.Clinical Trials—trends, charts and maps. https://clinicaltrials.gov/ct2/resources/trends.
- 2.E6(R2) Good clinical practice: integrated addendum to ICH E6(R1). U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r2-good-clinical-practice-integrated-addendum-ich-e6r1.
- 3.E6(R2) Good clinical practice: integrated addendum to E6(R1); International Council for Harmonisation; Guidance for Industry; Availability. https://www.regulations.gov/document?D=FDA-2018-D-0719-0001.
- 4.CITI program. https://about.citiprogram.org/en/mission-and-history/.
- 5.National Institutes of Health—policy and compliance. https://grants.nih.gov/policy/clinical-trials/good-clinical-training.htm.
- 6.Policy on good clinical practice training for NIH awardees involved in NIH-funded clinical trials. 2016. National Institutes of Health (NIH). https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-148.html.
- 7.NCI guidelines: adverse event reporting requirements. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/aeguidelines.pdf.
- 8.21 CFR 312.64b, 21 CFR 812 (code of federal regulation title 21). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=312.64.
- 9.Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33(8):910–5. https://doi.org/10.1200/JCO.2014.57.9334.CrossRefPubMedGoogle Scholar
- 10.Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22(17):3485–90. https://doi.org/10.1200/JCO.2004.03.025.CrossRefPubMedGoogle Scholar
- 12.Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9) https://doi.org/10.1093/jnci/dju244.
- 14.ICH guidance E6: good clinical practice: consolidated guideline. US HHS, US FDA, CDER, CBER. 1996. http://www.fda.gov/downloads/Drugs/Guidances/ucm073122.pdf. Accessed 11 Jun 2013.
- 16.Good clinical data management practices. Belgium: Society for Clinical Data Management; 2009. Accessed 17 Jun 2013. http://www.swaggerinfosolutions.pro/sridevi/New%20Folder/ICRI/GCDMP_complete_OCT2009.pdf.
- 17.OnCore enterprise research CTMS. Forte. https://forteresearch.com/enterprise-research-oncore/.
- 18.eRegulatory solution for high-performing clinical research sites. Complion. https://complion.com/.
- 24.Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012;11:MR000030. https://doi.org/10.1002/14651858.MR000030.pub2.
- 25.Devereaux PJ, Manns BJ, Ghali WA, Quan H, Guyatt GH. The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials. 2002;23(4):380–8.CrossRefGoogle Scholar
- 27.21 CFR 11. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=11.
- 28.21 CFR 312.32–33. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRsearch.cfm?CFRPart=312.
- 29.21 CFR 312.56. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=312.56.
- 30.Cuccia M. How to advance your career through clinical research certification. Forte. https://forteresearch.com/news/how-to-advance-your-career-through-clinical-research-certification/.